본문 바로가기
KERD
논문KCI 등재

Validity of the diagnosis of diabetic microvascular complications in Korean national health insurance claim data

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류신경과학

초록

Background: There is inadequate information on the validation of diabetic microvascular complications in the Korean National Health Insurance Service data set. We aimed to validate the diagnostic algorithms regarding the nephropathy, neuropathy, and retinopathy of diabe- tes. Methods: From various secondary and tertiary medical centers, we selected 6,493 patients aged ≥ 40 years who were diagnosed with diabetic microvascular complications more than once based on codes in the 10th version of the International Classification of Diseases (ICD-10). During 2019 and 2020, we randomly selected the diagnoses of 200 patients, 100 from each of two hospitals. The positive predictive value (PPV), negative predictive value, error rate, sensi- tivity, and specificity were determined for each diabetic microvascular complication according to the ICD-10 codes, laboratory findings, diagnostic studies, and treatment procedure codes. Results: Among the 200 patients who visited the hospital more than once and had the diagnostic codes of diabetic microvascular complications, 142, 110, and 154 patients were confirmed to have the gold standard of diabetic nephropathy (PPV, 71.0%), diabetic neurop- athy (PPV, 55.0%), and diabetic retinopathy (PPV, 77.0%), respectively. The PPV and specificity of diabetic nephropathy (PPV, 71.0–81.4%; specificity, 10.3–53.4%), diabetic neuropathy (PPV, 55.0–81.3%; specificity, 66.7–76.7%) and diabetic retinopathy (PPV, 77.0–96.6%; specificity, 2.2– 89.1%) increased after combining them with the laboratory findings, diagnostic studies, and treatment procedures codes. These change trends were observed similarly for both hospitals. Conclusions: Defining diabetic microvascular complications using ICD-10 codes and their related examination codes may be a feasible method for studying diabetic complications.

Abstract

Background: There is inadequate information on the validation of diabetic microvascular complications in the Korean National Health Insurance Service data set. We aimed to validate the diagnostic algorithms regarding the nephropathy, neuropathy, and retinopathy of diabe- tes. Methods: From various secondary and tertiary medical centers, we selected 6,493 patients aged ≥ 40 years who were diagnosed with diabetic microvascular complications more than once based on codes in the 10th version of the International Classification of Diseases (ICD-10). During 2019 and 2020, we randomly selected the diagnoses of 200 patients, 100 from each of two hospitals. The positive predictive value (PPV), negative predictive value, error rate, sensi- tivity, and specificity were determined for each diabetic microvascular complication according to the ICD-10 codes, laboratory findings, diagnostic studies, and treatment procedure codes. Results: Among the 200 patients who visited the hospital more than once and had the diagnostic codes of diabetic microvascular complications, 142, 110, and 154 patients were confirmed to have the gold standard of diabetic nephropathy (PPV, 71.0%), diabetic neurop- athy (PPV, 55.0%), and diabetic retinopathy (PPV, 77.0%), respectively. The PPV and specificity of diabetic nephropathy (PPV, 71.0–81.4%; specificity, 10.3–53.4%), diabetic neuropathy (PPV, 55.0–81.3%; specificity, 66.7–76.7%) and diabetic retinopathy (PPV, 77.0–96.6%; specificity, 2.2– 89.1%) increased after combining them with the laboratory findings, diagnostic studies, and treatment procedures codes. These change trends were observed similarly for both hospitals. Conclusions: Defining diabetic microvascular complications using ICD-10 codes and their related examination codes may be a feasible method for studying diabetic complications.

참고문헌 (34)

  1. Leon BM, "Diabetes and cardiovascular disease:epidemiology, biological mechanisms, treatment recommendations and future research", World J Diabetes, 6, pp.1246~1258 (2015)
  2. 차선아, "Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes", Diabetes and Metabolism Journal, 40(3), pp.202~210 (2016), 대한당뇨병학회[DOI]
  3. Mengnan Li, "Metabolic Syndrome with Hyperglycemia and the Risk of Ischemic Stroke", Yonsei Medical Journal, 54(2), pp.283~287 (2013), 연세대학교의과대학[DOI]
  4. Schmidt AM, "Diabetes mellitus and cardiovascular disease", Arterioscler Thromb Vasc Biol, 39, pp.558~568 (2019)
  5. 신순애, "Effects of Diabetic Case Management on Knowledge, Self-Management Abilities, Health Behaviors, and Health Service Utilization for Diabetes in Korea", Yonsei Medical Journal, 56(1), pp.244~252 (2015), 연세대학교의과대학[DOI]
  6. Faselis C, "Microvascular complications of type 2 diabetes mellitus", Curr Vasc Pharmacol, 18, pp.117~124 (2020)
  7. 김정희, "Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea", Diabetes and Metabolism Journal, 35(6), pp.571~577 (2011), 대한당뇨병학회
  8. Unnikrishnan R, "Diabetes mellitus and its complications in India", Nat Rev Endocrinol, 12, pp.357~370 (2016)
  9. Lee SR, "Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population", Int J Cardiol, 236, pp.226~231 (2017)
  10. Chang Y, "Improved oral hygiene is associated with decreased risk of new-onset diabetes : a nationwide population-based cohort study", Diabetologia, 63, pp.924~933 (2020)
  11. Chang Y, "Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure : a nationwide population-based cohort study", Eur J Prev Cardiol, 27, pp.1835~1845 (2020)
  12. Cha MJ, "Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in asian patients with atrial fibrillation", Stroke, 48, pp.3040~3048 (2017)
  13. Lee J, "Cohort profile : the National Health Insurance service-national sample cohort(NHIS-NSC), south korea", Int J Epidemiol, 46, pp.e15~ (2017)
  14. Chang Y, "Better oral hygiene is associated with lower risk of stroke", J Periodontol, 92, pp.87~94 (2021)
  15. Stevens LA, "Evaluation of the modification of diet in renal disease study equation in a large diverse population", J Am Soc Nephrol, 18, pp.2749~2757 (2007)
  16. Perkovic V, "Canagliflozin and renal outcomes in type 2 diabetes and nephropathy", N Engl J Med, 380, pp.2295~2306 (2019)
  17. 김경진, "Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study", Diabetes and Metabolism Journal, 45(3), pp.368~378 (2021), 대한당뇨병학회[DOI]
  18. Claus D, "Assessment of diabetic neuropathy : definition of norm and discrimination of abnormal nerve function", Muscle Nerve, 16, pp.757~768 (1993)
  19. Krieger SM, "Sudomotor testing of diabetes polyneuropathy", Front Neurol, 9, pp.803~ (2018)
  20. Patel K, "Diabetic neuropathies", Muscle Nerve, 63, pp.22~30 (2021)
  21. Azhary H, "Peripheral neuropathy : differential diagnosis and management", Am Fam Physician, 81, pp.887~892 (2010)
  22. 조호찬, "The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients", Diabetes and Metabolism Journal, 34(2), pp.111~118 (2010), 대한당뇨병학회
  23. Lee CK, "Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean national health insurance service database", J Gastroenterol Hepatol, 35, pp.760~768 (2020)
  24. Kim HJ, "Associations of heart failure with susceptibility and severe complications of COVID-19 : a nationwide cohort study", J Med Virol, 94, pp.1138~1145 (2022)
  25. Umapathi T, "Guillain-Barré syndrome decreases in Singapore during the COVID-19 pandemic", J Peripher Nerv Syst, 26, pp.235~236 (2021)
  26. Seo HJ, "A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea", Asian Pac J Cancer Prev, 13, pp.6163~6368 (2012)
  27. 이수진, "지역암등록자료를 이용한 건강보험 암 청구자료의 민감도 추정", Healthcare Informatics Research, 8(2), pp.35~40 (2002), 대한의료정보학회
  28. Lee SS, "Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy asian population without underlying disease : a nationwide cohort study in Korea", Eur Heart J, 38, pp.2599~2607 (2017)
  29. 배순옥, "건강보험 청구 질병코드와 퇴원손상환자심층조사 질병코드 비교 연구", 보건행정학회지, 24(4), pp.322~329 (2014), 한국보건행정학회[DOI]
  30. Deshpande AD, "Epidemiology of diabetes and diabetes-related complications", Phys Ther, 88, pp.1254~1264 (2008)
  31. Park J, "Validation of diagnostic codes of major clinical outcomes in a national health insurance database", Int J Arrhythm, 20, pp.5~ (2019)
  32. Vinik AI, "The new age of sudomotor function testing: a sensitive and specific biomarker for diagnosis, estimation of severity, monitoring progression, and regression in response to intervention", Front Endocrinol(Lausanne), 6, pp.94~ (2015)
  33. Roncal-Jimenez C, "Mechanisms by which dehydration may lead to chronic kidney disease", Ann Nutr Metab, 66, pp.10~13 (2015)
  34. Yang Z, "Simple tests to screen for diabetic peripheral neuropathy", Cochrane Database Syst Rev, 2018, pp.CD010975~ (2018)

이 간행물의 다른 논문 (5건)